SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-161022
Filing Date
2012-04-13
Accepted
2012-04-12 19:10:25
Documents
5
Period of Report
2012-04-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d333485d8k.htm 8-K 19703
2 EX-1.1 d333485dex11.htm EX-1.1 139357
3 EX-5.1 d333485dex51.htm EX-5.1 10055
4 GRAPHIC g333485g65u73.gif GRAPHIC 2598
5 GRAPHIC g333485g91b45.gif GRAPHIC 2462
  Complete submission text file 0001193125-12-161022.txt   177576
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31918 | Film No.: 12757281
SIC: 2836 Biological Products, (No Diagnostic Substances)